Trial Profile
Proprietary Information - Exploratory (Non-Confirmatory) Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs MK 0354 (Primary)
- Indications Lipid metabolism disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck & Co
- 12 Dec 2006 Status change
- 23 May 2006 New trial record.